Absci Corp (ABSI) financials

NASDAQ · Health Care

$11.13 -8.02% Close Oct 30, 2026 Live

Absci revenue and earnings by year

Absci's revenue was $2.80 million in the fiscal year to December 31, 2025, down 38.2% from the year before. Net income was -$115 million, -4113.7% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 5.2% a year on average.

RevenueNet income
-$100M-$50.0M$0
2019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 7 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue3566552
Revenue growth-38.2%-20.7%-0.5%20.2%0.0%132.0%—
Operating income-125-109-116-107-75-13-6
Operating margin-4479.2%-2401.6%-2020.2%-1857.5%-1573.4%-278.3%-304.1%
Net income-115-103-111-105-101-14-7
Net margin-4113.7%-2274.1%-1933.6%-1825.4%-2111.3%-300.3%-319.6%
Diluted EPS-$0.84-$0.94-$1.20-$1.15-$2.08-$3.19—
Free cash flow-93-73-65-97-99-13-7

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ABSI in Markets.

See also: ABSI returns

No forecast, no recommendation. This page describes Absci Corp from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.